TrialHepatology international2020

Benefits of prolonged-release pirfenidone plus standard of care treatment in patients with advanced liver fibrosis: PROMETEO study.

Jorge Luis Poo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.